Summary:
A new market study, titled “Discover Global Melanoma Therapeutics Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.
Introduction
Global Melanoma Therapeutics Market
Melanoma is one of the major types of skin cancer that develops from pigment-containing cells called melanocytes. Malignant tumors are formed as a result of rapid multiplication of skin cells occurs due to unrepaired damage to the DNA structures in skin cells. Long exposure to sunlight which may result in sunburns due to UV radiations are the primary cause of melanoma. In certain cases, genetic transmission can also be cause for melanoma. Melanoma therapeutics refers to the treatment and remediation measures undertaken at special healthcare or oncological centres following diagnosis.
According to the World Health Organization (WHO), about 132,000 melanoma skin cancers occur each year globally making up about a third of all the reported cases of skin cancer. The major causes at a global level can be attributed to the ozone layer depletion resulting in higher UV radiation reaching the earth. Melanoma is one of the common types of cancer and the second most invasive cancer. The market is driven by the rising prevalence of melanoma, improvement in healthcare facilities, government initiatives and innovation of medicines with better efficiency.
Regarding the key companies and their products that have been covered in the market report, some of their key branded biologics are getting their patents expired during the forecast period which may, in turn, lead to an increase in the entry of biosimilars in this market. There is an increase in the number of FDA approvals and introduction of new drugs within a period of 6 years, from 2011 to 2016. Lack of awareness of the disease and high cost associated with the therapy are expected to hamper the market growth over the period of forecast.
@Get Free Sample Report at https://www.wiseguyreports.com/sample-request/4206959-global-melanoma-therapeutics-market-2019-2026
Key Players of Global Melanoma Therapeutics Market =>
Bristol-Myers Squibb Co., Merck and Co., Inc., F. Hoffmann-La Roche, Ltd., AB Science S.A., Amgen, Inc., Celgene Corp., Daiichi Sankyo Co., Eisai Co., Ltd., GlaxoSmithKline, plc., Pfizer, Inc., and Vical, Inc.
Market Segmentation
The report on the global melanoma therapeutics market studies the overall market in terms of the current status and size while presenting the market trends and proving the forecast. The market has been segmented by stage as Stage 0, Stage I, Stage II, Stage III and Stage IV and by therapy as Surgery, Immunotherapy, Targeted Therapy, Chemotherapy, and Radiation Therapy. Among these, Surgery segment is expected to account for the largest market share over the period of forecast. Removal of the tumor by the method of surgery is the primary treatment in melanoma therapeutics. Immunotherapy is another section of the market that is expected to grow at the highest CAGR over the period of forecast.
Regional Analysis
Geographically, the global melanoma therapeutics market is divided into North America, Europe, South America, Asia-Pacific and the Middle East and Africa. North America is expected to dominate the melanoma therapeutics market in the forecast period due to increasing prevalence of melanoma and technical advancements in the region. The global increase in awareness about the treatment of melanoma and improved healthcare facilities and infrastructure drives the market. Asia Pacific region is expected to grow at the highest CAGR over the period of forecast. Constant rise in the number of reported cases of melanoma coupled with increased demand for cost-efficient therapeutics and rising population are boosting the growth of the market with Australia being the leading country. The increase in government initiatives in developing countries of this region is another major market driver.
Industry News
Amgen Inc., an American multinational biopharmaceutical company and one of the world’s largest independent biotechnology companies, has its patent for Imlygic set to expire in 2021. This may have a worldwide impact on the melanoma therapeutics market and expected to offer opportunities for new biosimilars and the companies manufacturing them and hence driving the global growth.
@Enquiry Before Buying https://www.wiseguyreports.com/enquiry/4206959-global-melanoma-therapeutics-market-2019-2026
Major Key Points of Global Melanoma Therapeutics Market
- Global Melanoma Therapeutics Market Methodology and Scope
- Global Melanoma Therapeutics Market – Market Definition and Overview
- Global Melanoma Therapeutics Market – Executive Summary
- Global Melanoma Therapeutics Market – Market Dynamics
- Global Melanoma Therapeutics Market – Industry Analysis
- Global Melanoma Therapeutics Market – By Stage
- Global Melanoma Therapeutics Market – By Therapy
- Global Melanoma Therapeutics Market – By Region
- Global Market – Competitive Landscape
- Company Profiles
- Global Melanoma Therapeutics Market – Premium Insights
- Global Melanoma Therapeutics Market – DataM
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
